| 标题 |
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients With MTAP-Deleted Cancers AMG 193是一种临床阶段MTA协同PRMT5抑制剂,在临床前和MTAP缺失癌症患者中驱动抗肿瘤活性
|
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Discovery 作者:Brian Belmontes; Katherine K. Slemmons; Chun Su; Siyuan Liu; Antonia N. Policheni; et al 出版日期:2024 |
| 求助人 | |
| 下载 |